These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17220538)

  • 21. Extinction learning of rewards in the rat: is there a role for CB1 receptors?
    Hernandez G; Cheer JF
    Psychopharmacology (Berl); 2011 Sep; 217(2):189-97. PubMed ID: 21519986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
    Forget B; Coen KM; Le Foll B
    Psychopharmacology (Berl); 2009 Sep; 205(4):613-24. PubMed ID: 19484221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; Li C; Vadivel SK; Makriyannis A
    Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant.
    Justinova Z; Munzar P; Panlilio LV; Yasar S; Redhi GH; Tanda G; Goldberg SR
    Neuropsychopharmacology; 2008 Nov; 33(12):2870-7. PubMed ID: 18305459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
    Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug addiction.
    Justinova Z; Panlilio LV; Goldberg SR
    Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys.
    Justinova Z; Solinas M; Tanda G; Redhi GH; Goldberg SR
    J Neurosci; 2005 Jun; 25(23):5645-50. PubMed ID: 15944392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors.
    Centonze D; Rossi S; De Chiara V; Prosperetti C; Battista N; Bernardi G; Mercuri NB; Usiello A; Maccarrone M
    Eur J Neurosci; 2007 Mar; 25(6):1631-40. PubMed ID: 17408430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol.
    Biała G; Budzyńska B
    Pharmacol Rep; 2010; 62(5):797-807. PubMed ID: 21098863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
    Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R
    J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-sensitization treatment with rimonabant blocks the expression of cocaine-induced behavioral sensitization and c-Fos protein in mice.
    Marinho EAV; Oliveira-Lima AJ; Yokoyama TS; Santos-Baldaia R; Ribeiro LTC; Baldaia MA; da Silva RW; Hollais AW; Talhati F; Longo BM; Berro LF; Frussa-Filho R
    Pharmacol Biochem Behav; 2017 May; 156():16-23. PubMed ID: 28366798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid Mobilization in the Prelimbic Cortex.
    McReynolds JR; Doncheck EM; Li Y; Vranjkovic O; Graf EN; Ogasawara D; Cravatt BF; Baker DA; Liu QS; Hillard CJ; Mantsch JR
    Biol Psychiatry; 2018 Jul; 84(2):85-94. PubMed ID: 29100630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
    Schindler CW; Scherma M; Redhi GH; Vadivel SK; Makriyannis A; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist.
    Järbe TU; Harris MY; Li C; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):35-45. PubMed ID: 15167981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
    Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys.
    Justinová Z; Yasar S; Redhi GH; Goldberg SR
    J Neurosci; 2011 May; 31(19):7043-8. PubMed ID: 21562266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.